Search Results - "Teriparatide/administration"
-
1
Authors: et al.
Source: Revue Médicale Suisse. 21:783-787
Subject Terms: Antibodies, Monoclonal, Diphosphonates / administration & dosage, Drug Administration Schedule, Osteoporosis / complications, Osteoporosis / drug therapy, Denosumab / therapeutic use, Denosumab / administration & dosage, Diphosphonates / therapeutic use, Bone Density Conservation Agents / therapeutic use, Humans, Teriparatide / administration & dosage, Bone Density Conservation Agents / administration & dosage, Osteoporotic Fractures / prevention & control
File Description: application/pdf
-
2
Authors: et al.
Source: Osteoporos Int
Subject Terms: Aged, 80 and over, Lumbar Vertebrae, Bone Density Conservation Agents, Femur Neck, Middle Aged, Absorptiometry, Photon, Treatment Outcome, Imaging, Three-Dimensional, Bone Density, Teriparatide, Absorptiometry, Photon/methods [MeSH], Aged, 80 and over [MeSH], Osteoporotic Fractures/physiopathology [MeSH], Aged [MeSH], Osteoporosis, Postmenopausal/diagnostic imaging [MeSH], Osteoporosis, Postmenopausal/drug therapy [MeSH], Tomography, X-Ray Computed/methods [MeSH], Biosimilar Pharmaceuticals/pharmacology [MeSH], Cancellous Bone/diagnostic imaging [MeSH], Biosimilar Pharmaceuticals/administration, Osteoporosis, Postmenopausal/physiopathology [MeSH], Original Article, Bone Density Conservation Agents/therapeutic use [MeSH], Cancellous Bone/physiopathology [MeSH], Lumbar Vertebrae/physiopathology [MeSH], Biosimilar Pharmaceuticals/therapeutic use [MeSH], Imaging, Three-Dimensional/methods [MeSH], Lumbar Vertebrae/diagnostic imaging [MeSH], Biosimilar, Fracture, Teriparatide/pharmacology [MeSH], Female [MeSH], Bone Density Conservation Agents/administration, Bone Density/drug effects [MeSH], Ultrasonography/methods [MeSH], Humans [MeSH], Treatment Outcome [MeSH], HRpQCT, Retrospective Studies [MeSH], Femur Neck/physiopathology [MeSH], Middle Aged [MeSH], Osteoporosis, Osteoporotic Fractures/prevention, Bone Density Conservation Agents/pharmacology [MeSH], BMD, Teriparatide/therapeutic use [MeSH], Teriparatide/administration, Cancellous Bone/drug effects [MeSH], Osteoporotic Fractures/diagnostic imaging [MeSH], Cancellous Bone, Humans, Female, Tomography, X-Ray Computed, Biosimilar Pharmaceuticals, Osteoporotic Fractures, Osteoporosis, Postmenopausal, Aged, Retrospective Studies, Ultrasonography
-
3
Authors: et al.
Subject Terms: Endocrinology, Osteoporosis Choice decision aid, denosumab therapy, denosumab discontinuation, Zoledronate Treatment, rebound effect, bisphosphonates target bone, Romosozumab, romosozumab versus teriparatide, teriparatide administration, teriparatide therapy, teriparatide users, Fracture Risk Assessment score, fracture risk predictors, BMD Bone mineral density, Morphometry analysis, DEXA, dual energy X-ray absorptiometry, DXA method analysis
-
4
Authors: et al.
Source: ACS Applied Materials & Interfaces. 13:23314-23327
Subject Terms: 0301 basic medicine, Physiology, delivery platform, bone marrow density, dosage form, osteoporotic conditions, Administration, Oral, Biochemistry, 01 natural sciences, Rats, Sprague-Dawley, Mice, teriparatide administration, Teriparatide, Enterohepatic Circulation, padlock nanocarrier, Cancer, bone formation, Drug Carriers, Mice, Inbred ICR, 0303 health sciences, Chondroitin Sulfates, Recombinant Proteins, 3. Good health, Parathyroid Hormone, Oral Delivery, Female, Biological Sciences not elsewhere classified, PTH, Taurocholic Acid, Chemical Sciences not elsewhere classified, Ovariectomy, Biophysics, OVX, Bone and Bones, Mathematical Sciences not elsewhere classified, 03 medical and health sciences, 0103 physical sciences, Animals, Humans, S.C, taurocholic acid-conjugated chondro, Triple-Padlock Nanocarrier, Osteoblasts, osteoporotic tibias, 0104 chemical sciences, Rats, Oral administration, cure osteoporosis, Enterohepatic Circulation Pathway I, Nanoparticles, Osteoporosis, serum bone parameters, TCSA
Access URL: https://pubmed.ncbi.nlm.nih.gov/33587600
https://hanyang.elsevierpure.com/en/publications/oral-delivery-of-parathyroid-hormone-using-a-triple-padlock-nanoc
https://pubs.acs.org/doi/10.1021/acsami.0c22170
https://pubmed.ncbi.nlm.nih.gov/33587600/
https://pubag.nal.usda.gov/catalog/7390550
https://www.ncbi.nlm.nih.gov/pubmed/33587600 -
5
Traitements médicamenteux séquentiels de l’ostéoporose [Sequential drug treatments for osteoporosis]
Authors: et al.
Source: Revue medicale suisse, vol. 21, no. 914, pp. 783-787
Subject Terms: Humans, Osteoporosis/drug therapy, Osteoporosis/complications, Bone Density Conservation Agents/administration & dosage, Bone Density Conservation Agents/therapeutic use, Denosumab/administration & dosage, Denosumab/therapeutic use, Diphosphonates/administration & dosage, Diphosphonates/therapeutic use, Osteoporotic Fractures/prevention & control, Teriparatide/administration & dosage, Drug Administration Schedule, Antibodies, Monoclonal
File Description: application/pdf
-
6
Authors: et al.
Subject Terms: Area Under Curve, Calibration, Chromatography, High Pressure Liquid, Drug Stability, Half-Life, Healthy Volunteers, Humans, Immunoassay, Injections, Subcutaneous, Limit of Detection, Peptide Fragments/blood, Reproducibility of Results, Tandem Mass Spectrometry, Teriparatide/administration & dosage, Teriparatide/blood, PTH 1-33, PTH 1-34, Parathyroid hormone, Pharmacokinetic, Teriparatide, UHPLC-MS/MS
Relation: Journal of Pharmaceutical and Biomedical Analysis; https://iris.unil.ch/handle/iris/98991; serval:BIB_4CDAF4AA5D52; 000460713700025
-
7
Authors: et al.
Source: 中国・四国整形外科学会雑誌 / The Journal of the Chugoku-Shikoku Orthopaedic Association. 2023, 35(1):65
-
8
Authors:
Source: Eiken, P A & Abrahamsen, B 2017, ' Osteoporosebehandling kan pauseres efter individuel vurdering ', Ugeskrift for Laeger, bind 179, nr. 4, V05160327, s. 335-342 .
Subject Terms: Bone Density/drug effects, Teriparatide/administration & dosage, Middle Aged, Biomarkers/analysis, 3. Good health, Diphosphonates/administration & dosage, Withholding Treatment, Bone Remodeling/drug effects, Humans, Bone Density Conservation Agents/administration & dosage, Thiophenes/administration & dosage, Denosumab/administration & dosage, Precision Medicine, Aged, Osteoporosis/drug therapy
-
9
Authors:
Source: ISSN: 1660-9379 ; Revue médicale suisse, vol. 13, no. 559 (2017) p. 859-862.
Subject Terms: info:eu-repo/classification/ddc/616, Bone Density, Bone Density Conservation Agents/administration & dosage, Estrogen Replacement Therapy/methods, Humans, Osteoporosis/complications/drug therapy, Osteoporotic Fractures/prevention & control, Selective Estrogen Receptor Modulators/administration & dosage, Teriparatide/administration & dosage, Time Factors
Relation: info:eu-repo/semantics/altIdentifier/pmid/28727344; unige:106806
Availability: https://archive-ouverte.unige.ch/unige:106806
-
10
Authors:
Source: Utposten. 45(5):44
-
11
Authors:
Source: Revue médicale suisse, Vol. 9, No 369 (2013) pp. 125-31
Revue médicale suisse, Vol. 10 (2014) pp. 101-107
Revue médicale suisse, Vol. 8, No 324 (2012) pp. 109-15
Revue médicale suisse, Vol. 7, No 278 (2011) pp. 138-144
Revue médicale suisse, Vol. 11 (2015) pp. 108-113
Revue médicale suisse, Vol. 6, No 231 (2010) pp. 56-60,62Subject Terms: Osteoporosis/etiology/prevention & control, Bone Density Conservation Agents/therapeutic use, Vitamin D/administration & dosage/adverse effects, Indoles/administration & dosage/adverse effects, Risk Assessment, Calcium/administration & dosage, 618.97, Osteoporosis/prevention & control, Humans, Calcium, Dietary/administration & dosage, ddc:610, Antibodies, Monoclonal, Humanized/administration & dosage/adverse effects, Teriparatide/administration & dosage/adverse effects, Vitamin D/therapeutic use, Osteoporosis, Postmenopausal/prevention & control, ddc:616, Diphosphonates/administration & dosage/adverse effects, Osteoporotic Fractures/prevention & control, Diabetes Mellitus, Type 2/complications, Fractures, Bone/etiology/prevention & control, Nutritional Requirements, 3. Good health, Osteoporosis, Postmenopausal/complications/drug therapy, Treatment Outcome, ddc:618.97, Bone Density Conservation Agents/administration & dosage/adverse effects, Female, Diphosphonates/therapeutic use
File Description: application/pdf
-
12
Authors: Abrahamsen, Bo
Source: Abrahamsen, B 2015, ' Bone : Sequential osteoporosis treatment-the order of things ', Nature Reviews. Endocrinology, vol. 11, no. 10, pp. 570-572 . https://doi.org/10.1038/nrendo.2015.134
Subject Terms: 0301 basic medicine, 2. Zero hunger, 0303 health sciences, Bone Density Conservation Agents, Osteoporosis, Postmenopausal/drug therapy, Teriparatide/administration & dosage, Antibodies, Monoclonal, Humanized, Antibodies, 3. Good health, 03 medical and health sciences, Teriparatide, Monoclonal, Humanized/administration & dosage, Osteoporosis, Humans, Bone Density Conservation Agents/administration & dosage, Female, Postmenopausal/drug therapy, Osteoporosis, Postmenopausal, Antibodies, Monoclonal, Humanized/administration & dosage
Access URL: https://pubmed.ncbi.nlm.nih.gov/26260144
https://www.ncbi.nlm.nih.gov/pubmed/26260144
https://www.nature.com/articles/nrendo.2015.134.pdf
https://www.nature.com/articles/nrendo.2015.134
https://portal.findresearcher.sdu.dk/da/publications/bone-sequential-osteoporosis-treatment-the-order-of-things
http://europepmc.org/abstract/MED/26260144
https://portal.findresearcher.sdu.dk/da/publications/18de137c-da45-4fac-be23-d3a1c61a6ddb
https://doi.org/10.1038/nrendo.2015.134
https://portal.findresearcher.sdu.dk/da/publications/18de137c-da45-4fac-be23-d3a1c61a6ddb -
13
Authors: et al.
Source: Neer, R M, Arnaud, C D, Zanchetta, J R, Prince, R, Gaich, G A, Reginster, J Y, Hodsman, A B, Eriksen, E F, Ish-Shalom, S, Gentant, H K, Wang, O & Mitlak, B H 2001, 'Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis', N. Engl. J. Med., vol. 344, no. 19, pp. 1434-1441.
Subject Terms: 0301 basic medicine, Osteoporosis, Postmenopausal/complications/drug therapy/physiopathology, Injections, Subcutaneous, Teriparatide/administration & dosage/adverse effects/pharmacology/therapeutic use, Femur/drug effects, Spinal Fractures/etiology/prevention & control, Sciences de la santé humaine, Lumbar Vertebrae/drug effects, Fractures, Bone, 03 medical and health sciences, 0302 clinical medicine, Bone Density, Teriparatide, Humans, Femur, Human health sciences, 10. No inequality, Osteoporosis, Postmenopausal, 2. Zero hunger, 0303 health sciences, Lumbar Vertebrae, Dose-Response Relationship, Drug, Fractures, Bone/etiology/prevention & control, Bone Density/drug effects, 3. Good health, Spinal Fractures, Female, General & internal medicine, Médecine générale & interne
Access URL: https://pubmed.ncbi.nlm.nih.gov/11346808
https://pubmed.ncbi.nlm.nih.gov/11346808/
https://www.nejm.org/doi/10.1056/NEJM200105103441904
https://www.nejm.org/doi/abs/10.1056/NEJM200105103441904
https://research-repository.uwa.edu.au/en/publications/effect-of-parathyroid-hormone-1-34-on-fractures-and-bone-mineral-
http://www.scienceopen.com/document/vid/ccde258f-0d8b-4c44-b974-c8a9458d7d7f
https://www.ncbi.nlm.nih.gov/pubmed/11346808
http://core.ac.uk/display/13323103
https://pure.au.dk/portal/en/publications/fad9f1b0-cec4-11da-bee9-02004c4f4f50 -
14
Contributors: et al.
Subject Terms: Aged, Bisphosphonate-Associated Osteonecrosis of the Jaw/drug therapy, Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology, Bone Density Conservation Agents/administration & dosage, Bone Density Conservation Agents/therapeutic use, Dental Implants/adverse effects, Female, Humans, Teriparatide/administration & dosage, Teriparatide/therapeutic use, Treatment Outcome, BRONJ, teriparatide, parathyroid hormone, dental implant, CTX, osteocalcin
File Description: 222~226
Relation: IMPLANT DENTISTRY; J01041; https://ir.ymlib.yonsei.ac.kr/handle/22282913/139691; T201500777; 52955
-
15
Contributors: et al.
Source: T201404481.pdf
Subject Terms: Aged, 80 and over, Bone Density/drug effects, Bone Density Conservation Agents/administration & dosage, Bone Density Conservation Agents/pharmacology, Cohort Studies, Drug Administration Schedule, Female, Fractures, Compression/drug therapy, Compression/etiology, Humans, Incidence, Male, Middle Aged, Osteoporosis/complications, Osteoporotic Fractures/drug therapy, Osteoporotic Fractures/etiology, Retrospective Studies, Spinal Fractures/drug therapy, Spinal Fractures/etiology, Teriparatide/administration & dosage, Teriparatide/pharmacology, Time Factors, Treatment Outcome, Osteoporosis, duration, teriparatide, vertebral compression fracture
File Description: 1576~1583
Relation: YONSEI MEDICAL JOURNAL; J02813; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138374; T201404481; 49133
-
16
Authors: et al.
Source: Ugeskrift for Laeger. 167(8):898
-
17
Authors:
Source: Information från Läkemedelsverket. 15(2):22
-
18
Authors: Anonymous
Source: Information från Läkemedelsverket. 14(6-7):95
-
19
Authors:
Source: Eiken, P A & Abrahamsen, B 2017, 'Osteoporosebehandling kan pauseres efter individuel vurdering', Ugeskrift for Læger, bind 179, nr. 4, V05160327, s. 335-342.
Subject Terms: Aged, Biomarkers/analysis, Bone Density Conservation Agents/administration & dosage, Bone Density/drug effects, Bone Remodeling/drug effects, Denosumab/administration & dosage, Diphosphonates/administration & dosage, Humans, Middle Aged, Osteoporosis/drug therapy, Precision Medicine, Teriparatide/administration & dosage, Thiophenes/administration & dosage, Withholding Treatment
-
20
Authors:
Source: Ugeskrift for Laeger. 179(4):335
Nájsť tento článok vo Web of Science 
Full Text Finder